Article
Microarray as a first genetic test in global developmental delay: a cost-effectiveness analysis
16 Aug 2011
Abstract excerpt
AIM: Microarray technology has a significantly higher clinical yield than karyotyping in individuals with global developmental delay (GDD). Despite this, it has not yet been routinely implemented as a screening test owing to the perception that this approach is more expensive. We aimed to evaluate the effect that replacing karyotype with array-based comparative genomic hybridization (aCGH) would have on the total...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
